After a period of sluggish deal activity, mergers and acquisitions in the biotechnology sector are showing signs of recovery.

Government policies under scrutiny in Australia’s cost-of-living debate As Australians continue to grapple with rising living ...

Global tech stocks have staged a surprising recovery in the face of significant market turbulence. The recent sell-off, ...

US consumer confidence dipped in January, according to the Conference Board's latest report, signaling potential headwinds ...